These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32280884)
1. From Ugi Multicomponent Reaction to Linkers for Bioconjugation. Ramos-Tomillero I; Pérez-Chacon G; Somovilla-Crespo B; Sánchez-Madrid F; Cuevas C; Zapata JM; Domínguez JM; Rodríguez H; Albericio F ACS Omega; 2020 Apr; 5(13):7424-7431. PubMed ID: 32280884 [TBL] [Abstract][Full Text] [Related]
2. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)]. Tsuchikama K Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230 [TBL] [Abstract][Full Text] [Related]
3. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development. Singh D; Dheer D; Samykutty A; Shankar R J Control Release; 2021 Dec; 340():1-34. PubMed ID: 34673122 [TBL] [Abstract][Full Text] [Related]
4. Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers. Salomon PL; Reid EE; Archer KE; Harris L; Maloney EK; Wilhelm AJ; Miller ML; Chari RVJ; Keating TA; Singh R Mol Pharm; 2019 Dec; 16(12):4817-4825. PubMed ID: 31609629 [TBL] [Abstract][Full Text] [Related]
5. Site-Selective Protein Conjugation by a Multicomponent Ugi Reaction. Koutsopetras I; Vaur V; Benazza R; Diemer H; Sornay C; Ersoy Y; Rochet L; Longo C; Hernandez-Alba O; Erb S; Detappe A; Skerra A; Wagner A; Cianferani S; Chaubet G Chemistry; 2024 Mar; 30(14):e202303242. PubMed ID: 38050774 [TBL] [Abstract][Full Text] [Related]
6. Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate. Sheyi R; de la Torre BG; Albericio F Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214128 [TBL] [Abstract][Full Text] [Related]
7. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry. Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414 [TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates. Tedeschini T; Campara B; Grigoletto A; Bellini M; Salvalaio M; Matsuno Y; Suzuki A; Yoshioka H; Pasut G J Control Release; 2021 Sep; 337():431-447. PubMed ID: 34329685 [TBL] [Abstract][Full Text] [Related]
9. Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates. Kang MS; Kong TWS; Khoo JYX; Loh TP Chem Sci; 2021 Oct; 12(41):13613-13647. PubMed ID: 34760149 [TBL] [Abstract][Full Text] [Related]
10. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs. Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951 [TBL] [Abstract][Full Text] [Related]
11. Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker. Liubomirski Y; Tiram G; Scomparin A; Gnaim S; Das S; Gholap S; Ge L; Yeini E; Shelef O; Zauberman A; Berger N; Kalimi D; Toister-Achituv M; Schröter C; Dickgiesser S; Tonillo J; Shan M; Deutsch C; Sweeney-Lasch S; Shabat D; Satchi-Fainaro R J Control Release; 2024 Mar; 367():148-157. PubMed ID: 38228272 [TBL] [Abstract][Full Text] [Related]
12. Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency. Anami Y; Xiong W; Gui X; Deng M; Zhang CC; Zhang N; An Z; Tsuchikama K Org Biomol Chem; 2017 Jul; 15(26):5635-5642. PubMed ID: 28649690 [TBL] [Abstract][Full Text] [Related]
13. Sulfatase-cleavable linkers for antibody-drug conjugates. Bargh JD; Walsh SJ; Isidro-Llobet A; Omarjee S; Carroll JS; Spring DR Chem Sci; 2020 Jan; 11(9):2375-2380. PubMed ID: 34084399 [TBL] [Abstract][Full Text] [Related]
15. Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation. Christie RJ; Tiberghien AC; Du Q; Bezabeh B; Fleming R; Shannon A; Mao S; Breen S; Zhang J; Zhong H; Harper J; Wu H; Howard PW; Gao C Antibodies (Basel); 2017 Nov; 6(4):. PubMed ID: 31548535 [TBL] [Abstract][Full Text] [Related]
16. Antibody drug conjugates beyond cytotoxic payloads. Hobson AD Prog Med Chem; 2023; 62():1-59. PubMed ID: 37981349 [TBL] [Abstract][Full Text] [Related]
17. Application of Next-Generation Maleimides (NGMs) to Site-Selective Antibody Conjugation. Morais M; Forte N; Chudasama V; Baker JR Methods Mol Biol; 2019; 2033():15-24. PubMed ID: 31332744 [TBL] [Abstract][Full Text] [Related]
18. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates. Frigerio M; Kyle AF Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801 [TBL] [Abstract][Full Text] [Related]